Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 05, 2026 17:20 ET | Source: EPIK Biosciences Inc.

EPIK Biosciences Launches to Pioneer Ketamine-Powered Psychedelic Therapies to Transform Treatment of Mental Health, Pain, and Addiction

Advancing synergistic combination medicines, non-opioid solutions for chronic pain, neuropsychiatric disorders, and substance use disorders using patient-friendly delivery methods. AUSTIN, Texas, May...